S&P 500 7,316 -2.44% Nasdaq 24,443 -4.86% Dow Jones 51,594 -1.20% FTSE 100 10,948 +2.90% DAX 25,433 +2.71% Nikkei 225 61,867 -4.25% Hang Seng 25,859 +2.57% WTI Crude 84.90 +2.77% Gold 4,121 +1.15% US 10-Year Treasury Yield 4.622 -1.72% S&P 500 7,316 -2.44% Nasdaq 24,443 -4.86% Dow Jones 51,594 -1.20% FTSE 100 10,948 +2.90% DAX 25,433 +2.71% Nikkei 225 61,867 -4.25% Hang Seng 25,859 +2.57% WTI Crude 84.90 +2.77% Gold 4,121 +1.15% US 10-Year Treasury Yield 4.622 -1.72%

LATEST

Panama’s La Cosecha 2026 Turns Coffee Into Art and Gastronomy●LIC sets board meeting date to declare Q1 results 2026. Check details●Cathie Wood’s Ark Invest sells Bitmine, Bullish, Block shares as crypto stocks dip●Shell Reports $9.8 Billion in Adjusted Earnings as Energy Prices Surge●Retail investors broaden bets in Q1, flock to Vedanta, Wipro and Bajaj Auto●Fitch: Pemex Burden Costs Mexico a Notch, BBB- Holds●El Salvador Proposes Central American Union Modeled on EU●Peru Air Cargo Jumps 10.3% in May, Leads Latin America●Panama’s La Cosecha 2026 Turns Coffee Into Art and Gastronomy●LIC sets board meeting date to declare Q1 results 2026. Check details●Cathie Wood’s Ark Invest sells Bitmine, Bullish, Block shares as crypto stocks dip●Shell Reports $9.8 Billion in Adjusted Earnings as Energy Prices Surge●Retail investors broaden bets in Q1, flock to Vedanta, Wipro and Bajaj Auto●Fitch: Pemex Burden Costs Mexico a Notch, BBB- Holds●El Salvador Proposes Central American Union Modeled on EU●Peru Air Cargo Jumps 10.3% in May, Leads Latin America●

Emerging Markets

Brazil Semaglutide Race Opens as Anvisa Clears Five Pens

The Rio Times · 59m ago · 🇧🇷 Brazil

Brazil Semaglutide Race Opens as Anvisa Clears Five Pens

Brazil · Business Key Facts —Patent expiry Novo Nordisk’s semaglutide patent expired in March 2026, ending exclusivity for Ozempic and Wegovy in Brazil. —New registrations Anvisa registered five new semaglutide pens on July 29, 2026: Semavy, Owozy, Seemasun, Zempneo, and Orsema, joining EMS’s earlier Ozivy. —Regulatory classification Under Brazilian law these are new synthetic semaglutide […] The post Brazil Semaglutide Race Opens as Anvisa Clears Five Pens appeared first on The Rio Times .

Read the full story at The Rio Times →

More Emerging Markets

Panama’s La Cosecha 2026 Turns Coffee Into Art and Gastronomy

The Rio Times · 17m ago

Fitch: Pemex Burden Costs Mexico a Notch, BBB- Holds

The Rio Times · 27m ago

El Salvador Proposes Central American Union Modeled on EU

The Rio Times · 27m ago

Peru Air Cargo Jumps 10.3% in May, Leads Latin America

The Rio Times · 27m ago